Events Calendar
In This Section
Most Read Stories
Injury list grows with opener nearing for Browns
Browns take hit on offensive line
Indians' top pick excels on field
McCain surprises, picks Alaska governor as running mate
Police arrest 30, seize drugs in citywide sweep
High school schedule and results
Blogs:
Akron Law Café:
A Woman in the White House
The Heldenfiles:
"Opportunity Knocks" for Canton Family (Updated)
Patrick McManamon:
The Browns conclude preseason 0-4
Browns Bulletin:
Cliffs Notes: Bears vs Browns Review
Cleveland Browns:
Browns v. Lions: Fourth Quarter
Cleveland Indians:
Ten for ten. Playoffs possible?
Akron Aeros:
Aeros clinch wild card, celebrate
Akron Zips:
Zips top No. 3 Notre Dame
Varsity Letters:
Week 2 football scoreboard
Kent State Sports:
Kent State versus Boston College Preview
The Sports Mix:
Ohio State Buckeyes - BTN and TW Reach a Deal
Ohio Politics:
Ad Watch: Flashback to 2006, Stevens and Palin
All Da King's Men:
McCain Selects Sarah Palin For Vice President
Blog of Mass Destruction:
McCain's Faulty Judgment On Display With Palin Pick
HRLite House:
Friday HR Fun Thought - Couch-surfing
Akrocentric:
"Sunflower," a poem by Frank Steele
Akron Gamer:
A look at Madden NFL 09, pt. 2: Gameplay
BokBluster:
Barackopolis
Ohio Travels with Betty:
Connie asks about hotels and resorts near the lake.
Sound Check:
LeRoi Moore, Dave Matthews Band saxophonist dies
Tia's Trends:
Light at the end of the Tunnel?
Less about a vaccine and more about treatment and prevention
Published on Monday, Mar 31, 2008
Two human trials of a promising vaccine have been halted since late last year after reviews of the data indicated the vaccine did not protect the recipients but may have made them more likely to contract HIV infection.
Faced with those distressing results, the researchers have made the call, wisely, not to chase shadows. They will refocus attention on basic research and direct more of the available resources to developing approaches that improve current prevention and treatment alternatives. Disappointing as the development is, the failure of the vaccine route does not mean it is a permanent dead-end. Scientific breakthroughs rarely follow a deliberate timetable.
Much has been accomplished globally over the years. We know more about the nature of HIV/AIDS and about treatments and prevention. Total spending on HIV/AIDS has increased, rising between 1996 and 2007 from about $300 million to nearly $10 billion.
Still, HIV/AIDS is a potent global threat, weakening the fabric of societies and economies in many regions. A quarter-century later, the impact of the viral disease remains sobering.
The latest estimates from the World Health Organization and UNAIDS put the number of new infections at 6,800 per day. In 2007, HIV/AIDS claimed 2.1 million lives. More than 33 million people worldwide live with the infection.
The challenge in containing the AIDS pandemic goes well beyond a disappointing quest for a vaccine. The failure emphasizes again that for the foreseeable future, global success in controlling the viral infection will depend on applying the precautions research has taught in 25 years, the simplest of which is to avoid complacence about risky behavior.
Get the full article here.
